Apyx Medical (NASDAQ:APYX) Rating Increased to Strong-Buy at Craig Hallum

Apyx Medical (NASDAQ:APYX) was upgraded by research analysts at Craig Hallum to a “strong-buy” rating in a research note issued to investors on Thursday, Zacks.com reports.

Other research analysts have also recently issued research reports about the stock. BTIG Research started coverage on shares of Apyx Medical in a report on Thursday, October 17th. They set a “neutral” rating for the company. JMP Securities reissued a “market perform” rating on shares of Apyx Medical in a research report on Monday, September 16th.

Apyx Medical Stock Performance

APYX stock opened at $1.21 on Thursday. The company has a quick ratio of 4.45, a current ratio of 5.33 and a debt-to-equity ratio of 2.26. Apyx Medical has a twelve month low of $0.97 and a twelve month high of $3.26. The business’s fifty day moving average is $1.22 and its 200-day moving average is $1.34. The company has a market cap of $41.92 million, a P/E ratio of -1.83 and a beta of 1.20.

Apyx Medical (NASDAQ:APYX) last released its earnings results on Thursday, August 8th. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.18) by ($0.01). The company had revenue of $12.15 million during the quarter, compared to analyst estimates of $12.67 million. Apyx Medical had a negative net margin of 57.86% and a negative return on equity of 105.45%. During the same period in the previous year, the company posted ($0.11) EPS. Equities research analysts forecast that Apyx Medical will post -0.7 EPS for the current year.

Hedge Funds Weigh In On Apyx Medical

Institutional investors have recently modified their holdings of the business. Private Advisor Group LLC increased its stake in Apyx Medical by 3.9% during the 3rd quarter. Private Advisor Group LLC now owns 322,321 shares of the company’s stock worth $400,000 after purchasing an additional 12,180 shares in the last quarter. Commonwealth Equity Services LLC lifted its stake in Apyx Medical by 2.9% in the second quarter. Commonwealth Equity Services LLC now owns 511,561 shares of the company’s stock valued at $685,000 after buying an additional 14,481 shares in the last quarter. Perkins Capital Management Inc. boosted its holdings in shares of Apyx Medical by 7.0% in the first quarter. Perkins Capital Management Inc. now owns 228,500 shares of the company’s stock valued at $311,000 after buying an additional 15,000 shares during the period. Kingsview Wealth Management LLC increased its position in shares of Apyx Medical by 156.7% during the first quarter. Kingsview Wealth Management LLC now owns 31,028 shares of the company’s stock worth $42,000 after acquiring an additional 18,943 shares in the last quarter. Finally, RPg Family Wealth Advisory LLC acquired a new stake in shares of Apyx Medical during the second quarter worth $101,000. Institutional investors own 55.33% of the company’s stock.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.